US 12428376
Therapeutic compounds and compositions
granted A61KA61K31/497A61K31/5513
Quick answer
US patent 12428376 (Therapeutic compounds and compositions) held by Agios Pharmaceuticals, Inc. expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/497, A61K31/5513, A61P, A61P35/00